A system for the large?scale production of membrane proteins - membrane proteins play a fundamental and critical role in cellular processes
Ended Project Grant Awarded Last action
- Award ID
- R43GM137735
- Recipient
-
Chesapeake Genomic Systems, LLC UEI F6ZVG7CX33T1
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $469,359
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date
- Originally
- Place of performance
- Maryland, USA
Award details come from USAspending.gov.
Description
Their direct link to human disease as well as their key role in signal transduction, has made many membrane proteins the foremost targets for chemotherapeutic intervention with more than 50% of all drugs designed to modulate the activity of this class of proteins. Despite this central role in human health, the biochemical, functional and structural properties of membrane proteins remain poorly understood. This is partially due to the inherent challenges of isolating membrane proteins in sufficient quantities and levels of purity needed for biochemical characterization. The traditional approach of using heterologous protein expression systems to synthesize recombinant membrane proteins has been marginally successful. No one system has emerged as universally applicable and the process of producing recombinant membrane proteins remains one of trial and error. To address this bottleneck in the study of membrane proteins and in the development of new treatment options, we have proposed the use of the thylakoid membrane system of the unicellular green algae chlamydomonas as a more suitable platform for the production of recombinant membrane proteins. The proposed research aims to demonstrate the feasibility of using such a system by building a set of specialized vectors that direct the expression of membrane proteins to the thylakoid membrane and to test the utility of the system using two medically relevant membrane proteins.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $239,783 | |
| Amendment | $239,783 | |
| Amendment | $239,783 | |
| Amendment | -$249,990 | |
| Amendment | -$249,990 | |
| Amendment | -$249,990 | |
| Amendment | -$249,990 | |
| Amendment | $249,990 | |
| Amendment | $249,990 | |
| Original award | $249,990 |
Show all 13
Quick answers
Who received award R43GM137735?
R43GM137735 was awarded to Chesapeake Genomic Systems, LLC by National Institute of General Medical Sciences (National Institutes of Health) on October 1, 2022.
How much is award R43GM137735 worth?
$469,359 has been obligated on R43GM137735.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award